Reliability and validity of the Korean version of the European organization for research and treatment of cancer quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy

Hye Young Kim, Jeong Hee Kang, Hyun Jo Youn, Hyang Sook So, Chi Eun Song, Seo Young Chae, Sung Hoo Jung, Sung Reul Kim, Ji Young Kim

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: This study was performed to assess the reliability and validity of the Korean version of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-induced peripheral neuropathy 20 items (EORTC QLQ-CIPN20) in patients receiving neurotoxic chemotherapy. Methods: A convenience sample of 249 Korean cancer patients, previously or currently, being treated with peripheral neurotoxic chemotherapeutic agents were asked to fill in the questionnaire. Collected data were analyzed using SPSS 21.0 and AMOS 21.0. Construct validity, known-group validity, concurrent validity, and internal consistency reliability of the Korean version of the QLQ-CIPN20 were evaluated. Results: Factor analysis confirmed 3 dimensions of CIPN: sensory, motor, and autonomic. The factor loadings of the 20 items on the 3 subscales ranged from. 38 to. 85. The 3 subscale-model was validated by confirmatory factor analysis (GFI=.90, AGFI=.86, RMSR=.05, NFI=.87, and CFI=.94), and concurrent validity was demonstrated with the EORTC QLQC30. Furthermore, the QLQ-CIPN20 established known-group validity. The Cronbach’s alpha coefficients for internal consistency of the subscales ranged from. 73 to. 89. Conclusion: The Korean version of the EORTC QLQ-CIPN20 showed satisfactory construct, concurrent, and known-group validity, as well as internal reliability.

Original languageEnglish
Pages (from-to)735-742
Number of pages8
JournalJournal of Korean Academy of Nursing
Volume44
Issue number6
DOIs
Publication statusPublished - 2014 Dec 1
Externally publishedYes

Fingerprint

Peripheral Nervous System Diseases
Reproducibility of Results
Quality of Life
Organizations
Drug Therapy
Statistical Factor Analysis
Research
Neoplasms
Therapeutics
Surveys and Questionnaires

Keywords

  • Chemotherapy
  • Peripheral neuropathies
  • Reliability
  • Validity

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Reliability and validity of the Korean version of the European organization for research and treatment of cancer quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy. / Kim, Hye Young; Kang, Jeong Hee; Youn, Hyun Jo; So, Hyang Sook; Song, Chi Eun; Chae, Seo Young; Jung, Sung Hoo; Kim, Sung Reul; Kim, Ji Young.

In: Journal of Korean Academy of Nursing, Vol. 44, No. 6, 01.12.2014, p. 735-742.

Research output: Contribution to journalArticle

Kim, Hye Young ; Kang, Jeong Hee ; Youn, Hyun Jo ; So, Hyang Sook ; Song, Chi Eun ; Chae, Seo Young ; Jung, Sung Hoo ; Kim, Sung Reul ; Kim, Ji Young. / Reliability and validity of the Korean version of the European organization for research and treatment of cancer quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy. In: Journal of Korean Academy of Nursing. 2014 ; Vol. 44, No. 6. pp. 735-742.
@article{f536b7df4e0a4d9fb438ad43cfbe5dce,
title = "Reliability and validity of the Korean version of the European organization for research and treatment of cancer quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy",
abstract = "Purpose: This study was performed to assess the reliability and validity of the Korean version of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-induced peripheral neuropathy 20 items (EORTC QLQ-CIPN20) in patients receiving neurotoxic chemotherapy. Methods: A convenience sample of 249 Korean cancer patients, previously or currently, being treated with peripheral neurotoxic chemotherapeutic agents were asked to fill in the questionnaire. Collected data were analyzed using SPSS 21.0 and AMOS 21.0. Construct validity, known-group validity, concurrent validity, and internal consistency reliability of the Korean version of the QLQ-CIPN20 were evaluated. Results: Factor analysis confirmed 3 dimensions of CIPN: sensory, motor, and autonomic. The factor loadings of the 20 items on the 3 subscales ranged from. 38 to. 85. The 3 subscale-model was validated by confirmatory factor analysis (GFI=.90, AGFI=.86, RMSR=.05, NFI=.87, and CFI=.94), and concurrent validity was demonstrated with the EORTC QLQC30. Furthermore, the QLQ-CIPN20 established known-group validity. The Cronbach’s alpha coefficients for internal consistency of the subscales ranged from. 73 to. 89. Conclusion: The Korean version of the EORTC QLQ-CIPN20 showed satisfactory construct, concurrent, and known-group validity, as well as internal reliability.",
keywords = "Chemotherapy, Peripheral neuropathies, Reliability, Validity",
author = "Kim, {Hye Young} and Kang, {Jeong Hee} and Youn, {Hyun Jo} and So, {Hyang Sook} and Song, {Chi Eun} and Chae, {Seo Young} and Jung, {Sung Hoo} and Kim, {Sung Reul} and Kim, {Ji Young}",
year = "2014",
month = "12",
day = "1",
doi = "10.4040/jkan.2014.44.6.735",
language = "English",
volume = "44",
pages = "735--742",
journal = "Asian Nursing Research",
issn = "2005-3673",
publisher = "Taehan Kanho Hakhoe",
number = "6",

}

TY - JOUR

T1 - Reliability and validity of the Korean version of the European organization for research and treatment of cancer quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy

AU - Kim, Hye Young

AU - Kang, Jeong Hee

AU - Youn, Hyun Jo

AU - So, Hyang Sook

AU - Song, Chi Eun

AU - Chae, Seo Young

AU - Jung, Sung Hoo

AU - Kim, Sung Reul

AU - Kim, Ji Young

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Purpose: This study was performed to assess the reliability and validity of the Korean version of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-induced peripheral neuropathy 20 items (EORTC QLQ-CIPN20) in patients receiving neurotoxic chemotherapy. Methods: A convenience sample of 249 Korean cancer patients, previously or currently, being treated with peripheral neurotoxic chemotherapeutic agents were asked to fill in the questionnaire. Collected data were analyzed using SPSS 21.0 and AMOS 21.0. Construct validity, known-group validity, concurrent validity, and internal consistency reliability of the Korean version of the QLQ-CIPN20 were evaluated. Results: Factor analysis confirmed 3 dimensions of CIPN: sensory, motor, and autonomic. The factor loadings of the 20 items on the 3 subscales ranged from. 38 to. 85. The 3 subscale-model was validated by confirmatory factor analysis (GFI=.90, AGFI=.86, RMSR=.05, NFI=.87, and CFI=.94), and concurrent validity was demonstrated with the EORTC QLQC30. Furthermore, the QLQ-CIPN20 established known-group validity. The Cronbach’s alpha coefficients for internal consistency of the subscales ranged from. 73 to. 89. Conclusion: The Korean version of the EORTC QLQ-CIPN20 showed satisfactory construct, concurrent, and known-group validity, as well as internal reliability.

AB - Purpose: This study was performed to assess the reliability and validity of the Korean version of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-induced peripheral neuropathy 20 items (EORTC QLQ-CIPN20) in patients receiving neurotoxic chemotherapy. Methods: A convenience sample of 249 Korean cancer patients, previously or currently, being treated with peripheral neurotoxic chemotherapeutic agents were asked to fill in the questionnaire. Collected data were analyzed using SPSS 21.0 and AMOS 21.0. Construct validity, known-group validity, concurrent validity, and internal consistency reliability of the Korean version of the QLQ-CIPN20 were evaluated. Results: Factor analysis confirmed 3 dimensions of CIPN: sensory, motor, and autonomic. The factor loadings of the 20 items on the 3 subscales ranged from. 38 to. 85. The 3 subscale-model was validated by confirmatory factor analysis (GFI=.90, AGFI=.86, RMSR=.05, NFI=.87, and CFI=.94), and concurrent validity was demonstrated with the EORTC QLQC30. Furthermore, the QLQ-CIPN20 established known-group validity. The Cronbach’s alpha coefficients for internal consistency of the subscales ranged from. 73 to. 89. Conclusion: The Korean version of the EORTC QLQ-CIPN20 showed satisfactory construct, concurrent, and known-group validity, as well as internal reliability.

KW - Chemotherapy

KW - Peripheral neuropathies

KW - Reliability

KW - Validity

UR - http://www.scopus.com/inward/record.url?scp=84922287655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922287655&partnerID=8YFLogxK

U2 - 10.4040/jkan.2014.44.6.735

DO - 10.4040/jkan.2014.44.6.735

M3 - Article

C2 - 25608551

AN - SCOPUS:84922287655

VL - 44

SP - 735

EP - 742

JO - Asian Nursing Research

JF - Asian Nursing Research

SN - 2005-3673

IS - 6

ER -